Conceptus, Inc. Reports Fourth Quarter Sales Growth of 30%, Diluted EPS of $0.21

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Conceptus, Inc. (Nasdaq: CPTS), developer of the Essure® procedure, the first proven non-surgical permanent birth control method available, today reported financial results for the three and 12 months ended December 31, 2009.